COVID-19 Antibody Testing Package
Total Package, Including 15-20 minute immune-boosting consult: $150
COVID19 Antibody Testing Now Available at SOPHIA
We are excited to offer COVID-19 Antibody Testing at SOPHIA Natural Health Center! This test is designed to detect exposure to the virus through the presence of antibodies in the blood. Get tested and receive a 15-20 minute consultation with Dr. Eli on how best to protect yourself from future exposure to the coronavirus.
Many of you may have heard that antibody testing is not completely reliable at this time. This is mainly due to the FDA not having time to screen and approve this much needed test. In an unusual but necessary move the FDA has allowed labs to develop antibody tests and offer them to the public in order to help individuals better understand their exposure history and possible susceptibility to a future infection. We chose the Boston Heart antibody test, created by Diazyme Lab, because it has been validated against cross reactions with other common viruses, including other common corona viruses. That means this test has proven that it is very specific and sensitive for antibodies to the corona virus that causes Covid-19. Basically, it is the best test currently out there.
How do I get this test?
Make an appointment with our front desk by calling: 203-740-9300
When can I get the test?
Our lab will be open on Wednesdays.
I heard testing involves an uncomfortable nasal swab, is that true?
The test is an in-office blood draw. No swabs involved.
**Boston Heart Disclaimer: IgM and IgG Antibody testing. These assays are used for the detection of IgM and IgG antibodies against SARS-CoV-2 in human serum or plasma. This testing has not been reviewed by the FDA, but the manufacturer and our laboratory have notified the FDA that these tests have been validated in accordance with Section IV.D. of the FDA’s “Policy for Diagnostic Tests for Coronavirus Disease-2019 (COVID-19) during the Public Health Emergency”, and both the manufacturer (Diazyme) and our laboratory are listed on the FDA website as offering tests under this policy. Negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus. Follow-up testing with a molecular diagnostic assay should be considered to rule out infection in these individuals. Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status.